Compare AANJANEYA LIFECARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ABBOTT INDIA DR. DATSONS LABS/
ABBOTT INDIA
 
P/E (TTM) x -10.9 47.1 - View Chart
P/BV x 0.2 15.2 1.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ABBOTT INDIA
Mar-19
DR. DATSONS LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1268,834 1.4%   
Low Rs315,458 0.6%   
Sales per share (Unadj.) Rs133.01,731.1 7.7%  
Earnings per share (Unadj.) Rs0.2211.9 0.1%  
Cash flow per share (Unadj.) Rs6.6219.9 3.0%  
Dividends per share (Unadj.) Rs065.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8945.2 13.6%  
Shares outstanding (eoy) m31.6621.25 149.0%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.1 14.3%   
Avg P/E ratio x516.133.7 1,530.6%  
P/CF ratio (eoy) x11.832.5 36.4%  
Price / Book Value ratio x0.67.6 8.0%  
Dividend payout %030.7 0.0%   
Avg Mkt Cap Rs m2,477151,848 1.6%   
No. of employees `000NA3.5 0.0%   
Total wages/salary Rs m564,356 1.3%   
Avg. sales/employee Rs ThNM10,555.5-  
Avg. wages/employee Rs ThNM1,249.9-  
Avg. net profit/employee Rs ThNM1,292.2-  
INCOME DATA
Net Sales Rs m4,21136,786 11.4%  
Other income Rs m791,133 6.9%   
Total revenues Rs m4,28937,919 11.3%   
Gross profit Rs m5696,047 9.4%  
Depreciation Rs m204169 120.8%   
Interest Rs m43023 1,912.0%   
Profit before tax Rs m136,989 0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m62,485 0.2%   
Profit after tax Rs m54,503 0.1%  
Gross profit margin %13.516.4 82.1%  
Effective tax rate %48.035.6 135.1%   
Net profit margin %0.112.2 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,85227,610 24.8%   
Current liabilities Rs m6,7118,569 78.3%   
Net working cap to sales %3.351.8 6.5%  
Current ratio x1.03.2 31.7%  
Inventory Days Days16160 267.1%  
Debtors Days Days31827 1,162.5%  
Net fixed assets Rs m3,6731,057 347.5%   
Share capital Rs m317213 149.0%   
"Free" reserves Rs m3,76119,873 18.9%   
Net worth Rs m4,07820,086 20.3%   
Long term debt Rs m1,6710-   
Total assets Rs m12,63329,409 43.0%  
Interest coverage x1.0311.6 0.3%   
Debt to equity ratio x0.40-  
Sales to assets ratio x0.31.3 26.6%   
Return on assets %3.415.4 22.4%  
Return on equity %0.122.4 0.5%  
Return on capital %7.734.9 22.0%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m964369 261.3%   
Fx outflow Rs m6074,918 12.3%   
Net fx Rs m357-4,549 -7.8%   
CASH FLOW
From Operations Rs m1,3454,991 26.9%  
From Investments Rs m-2,256-2,570 87.8%  
From Financial Activity Rs m-1,200-1,428 84.0%  
Net Cashflow Rs m-2,111993 -212.5%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 0.0 7.9 -  
FIIs % 1.4 0.1 1,350.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 17.1 550.3%  
Shareholders   20,807 18,270 113.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  WYETH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views on News

ABBOTT INDIA Announces Quarterly Results (3QFY21); Net Profit Down 5.1% (Quarterly Result Update)

Feb 11, 2021 | Updated on Feb 11, 2021

For the quarter ended December 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (down 5.1% YoY). Sales on the other hand came in at Rs 11 bn (up 1.6% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY21); Net Profit Up 54.2% (Quarterly Result Update)

Aug 18, 2020 | Updated on Aug 18, 2020

For the quarter ended June 2020, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 54.2% YoY). Sales on the other hand came in at Rs 11 bn (up 6.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY20); Net Profit Down 2.0% (Quarterly Result Update)

Jun 9, 2020 | Updated on Jun 9, 2020

For the quarter ended March 2020, ABBOTT INDIA has posted a net profit of Rs 1 bn (down 2.0% YoY). Sales on the other hand came in at Rs 10 bn (up 6.1% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY20); Net Profit Up 59.5% (Quarterly Result Update)

Feb 11, 2020 | Updated on Feb 11, 2020

For the quarter ended December 2019, ABBOTT INDIA has posted a net profit of Rs 2 bn (up 59.5% YoY). Sales on the other hand came in at Rs 11 bn (up 13.8% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living(Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - NOVARTIS COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS